HOME | SITEMAP | CONTACT US









 
   
About the NCCR
Committee Members
Services & Guidelines
Good Clinical Practice (GCP)
Guideline on the Use of Human Biological Tissues for Research
Guidelines for Ethical Review of Clinical Research or Research involving human subjects
Guidelines for Application of Clinical Trial Import Licence and Clinical Trial Exemption in Malaysia
Guidelines for Good Clinical Practice (GCP) Inspection
Malaysian Guideline for Safety Reporting of Investigational Products
Malaysian Guideline for Independent Ethics Committee Registration and Inspection
Malaysian Guideline for Bioequivalence Inspection
International Ethical Guidelines for Biomedical Research (CIOMS 2002)
Operational Guidelines for Ethics Committees That Review Biomedical Research (WHO 2000)
Approved Research
Clinical Investigators
Useful Links
NCCR Bulletin
MOH News
Contact Us







  Malaysian Guideline for Independent Ethics Committee Registration and Inspection

[ Download the Malaysian Guideline for Independent Ethics Committee Registration and Inspection here - PDF, 763KB ]

The Drug Control Authority (DCA)'s mission is to ensure the implementation of Good Clinical Practice (GCP), which is an international ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve the participation of human subjects. Ethnics committees play a crucial role in assessing the scientific and ethical aspects of a clinical trial to safeguard the rights, safety and well-being of clinical trial subjects. In recent years, National Pharmaceutical Control Bureau, in particular of Center for Investigational New Products has expanded its activities in ethical committee inspections. 

The DCA is at the forefront to create an eco-system environment in clinical research platform to ensure all parties involved in clinical trials in Malaysia comply with the principles embossed in the GCP. Independent ethics committee inspection plays an important role in upholding the quality conduct of an ethic committee in line with international ethical practice and requirements. 

This guideline, Malaysian Guideline for Independent Ethics Committee Registration and Inspection, 1st edition specifically narrates the registration process for a new ethical committee, conduct of ethical committee inspection and administrative maintenance of ethical committee with DCA. This guideline supersedes the appendix Vi in the Guideline for Good Clinical Practice Inspection Programme.

I would like to express my deepest appreciation to the committee members and stakeholders whom inspired and shared their insight to develop this guideline. It is my pleasure that this guideline will contribute to catalyst the process of ethics committee registration and inspection. 

 

Tan Ann Ling
Director of Pharmacy Regulatory
National Pharmaceutical Control Bureau
Ministry of Health Malaysia

May 2016

 

Download the Malaysian Guideline for Independent Ethics Committee Registration and Inspection here - PDF, 763KB ]

 

 

 



 Print Friendly [ Total Hits: 441590 | Page Hits: 197 ]

 
 

This website is managed and sponsored by the Clinical Research Centre, Ministry of Health Malaysia
Copyright © 2005 - 2018 National Committee for Clinical Research (NCCR). All Rights Reserved.  
Powered by Cornerstone Content Management System